Clinical trial
A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children
NCT00468819 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00468819 |
|---|---|
| Title | A Study of Magnetic Resonance Imaging (MRI) With Gadavist in Children |
| Official title | Open-label Multi-center Study of Magnetic Resonance Imaging (MRI) With 0.1 mmol/kg Body Weight (BW) Gadavist (1.0 M) to Assess Pharmacokinetics, Safety and Tolerability in Children. |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Magnetic Resonance Imaging |
| Intervention type | Drug |
| Interventions | Gadobutrol (Gadavist, Gadovist, BAY86-4875) |
| Enrollment | 140 |
| Start date | May 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 3, 2007 |
| Last update posted | Jul 22, 2015 |
| Countries | Austria, Canada, Germany, Sweden |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: